Globus Medical, Inc. (GMED): Price and Financial Metrics
GMED Price/Volume Stats
Current price | $53.64 | 52-week high | $62.88 |
Prev. close | $53.06 | 52-week low | $43.38 |
Day low | $52.91 | Volume | 764,300 |
Day high | $53.98 | Avg. volume | 1,181,862 |
50-day MA | $53.68 | Dividend yield | N/A |
200-day MA | $53.14 | Market Cap | 7.26B |
GMED Stock Price Chart Interactive Chart >
GMED POWR Grades
- GMED scores best on the Quality dimension, with a Quality rank ahead of 72.7% of US stocks.
- GMED's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
- GMED's current lowest rank is in the Stability metric (where it is better than 18.03% of US stocks).
GMED Stock Summary
- GMED's current price/earnings ratio is 45.32, which is higher than 84.43% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for GMED is currently 35.28, higher than 89.01% of US stocks with positive operating cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for GLOBUS MEDICAL INC; that's greater than it is for only 12.56% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to GLOBUS MEDICAL INC are WST, DHX, MTRN, ASH, and GNRC.
- GMED's SEC filings can be seen here. And to visit GLOBUS MEDICAL INC's official web site, go to www.globusmedical.com.
GMED Valuation Summary
- GMED's EV/EBIT ratio is 43.5; this is 197.95% higher than that of the median Healthcare stock.
- GMED's price/sales ratio has moved up 2.6 over the prior 139 months.
Below are key valuation metrics over time for GMED.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
GMED | 2023-12-29 | 6.0 | 1.8 | 46.5 | 43.5 |
GMED | 2023-12-28 | 6.1 | 1.8 | 47.1 | 44.1 |
GMED | 2023-12-27 | 6.0 | 1.7 | 46.4 | 43.4 |
GMED | 2023-12-26 | 6.1 | 1.8 | 47.2 | 44.1 |
GMED | 2023-12-22 | 6.0 | 1.8 | 46.8 | 43.8 |
GMED | 2023-12-21 | 6.1 | 1.8 | 47.1 | 44.0 |
GMED Growth Metrics
- Its 2 year price growth rate is now at 28.08%.
- The 2 year revenue growth rate now stands at 21.22%.
- The 3 year net cashflow from operations growth rate now stands at 52.71%.
The table below shows GMED's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 998.366 | 190.746 | 155.211 |
2022-06-30 | 973.939 | 235.088 | 154.991 |
2022-03-31 | 961.307 | 257.394 | 141.946 |
2021-12-31 | 958.102 | 276.274 | 149.191 |
2021-09-30 | 941.526 | 280.205 | 187.042 |
2021-06-30 | 927.903 | 256.191 | 184.047 |
GMED's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- GMED has a Quality Grade of B, ranking ahead of 90.91% of graded US stocks.
- GMED's asset turnover comes in at 0.547 -- ranking 84th of 186 Medical Equipment stocks.
- OFIX, SRTS, and ESMC are the stocks whose asset turnover ratios are most correlated with GMED.
The table below shows GMED's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.547 | 0.745 | 0.189 |
2021-03-31 | 0.514 | 0.729 | 0.131 |
2020-12-31 | 0.512 | 0.724 | 0.111 |
2020-09-30 | 0.510 | 0.732 | 0.103 |
2020-06-30 | 0.504 | 0.741 | 0.096 |
2020-03-31 | 0.542 | 0.764 | 0.165 |
Globus Medical, Inc. (GMED) Company Bio
Globus Medical focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company was founded in 2003 and is based in Audubon, Pennsylvania.
Latest GMED News From Around the Web
Below are the latest news stories about GLOBUS MEDICAL INC that investors may wish to consider to help them evaluate GMED as an investment opportunity.
4 Orthobiologic Stocks Set To Soar In 2024Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery fro... |
Here's Why You Should Retain Globus Medical (GMED) Stock NowInvestors are optimistic about Globus Medical (GMED) on growing demand for musculoskeletal devices and its strong solvency position. |
3 Stocks at the Forefront of Medical RoboticsEvery now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. |
Globus Medical (GMED) Down 3.1% Since Last Earnings Report: Can It Rebound?Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Globus Medical (GMED) Gains From NuVasive Deal, Macro Woes StayGlobus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings. |
GMED Price Returns
1-mo | -4.94% |
3-mo | 0.66% |
6-mo | 8.04% |
1-year | 0.32% |
3-year | -11.28% |
5-year | 8.56% |
YTD | 0.66% |
2023 | -28.25% |
2022 | 2.87% |
2021 | 10.70% |
2020 | 10.77% |
2019 | 36.04% |
Continue Researching GMED
Want to do more research on Globus Medical Inc's stock and its price? Try the links below:Globus Medical Inc (GMED) Stock Price | Nasdaq
Globus Medical Inc (GMED) Stock Quote, History and News - Yahoo Finance
Globus Medical Inc (GMED) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...